{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:20:21Z","timestamp":1769052021969,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Developmental Cell"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.devcel.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T14:25:02Z","timestamp":1635171902000},"page":"2785-2786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inhibition of ERK\/MAPK signaling as potential therapy to prevent optic pathway glioma in infants with neurofibromatosis type 1"],"prefix":"10.1016","volume":"56","author":[{"given":"Fulvio","family":"D\u2019Angelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lasorella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.devcel.2021.10.001_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41591-018-0263-8","article-title":"The molecular landscape of glioma in patients with Neurofibromatosis 1","volume":"25","author":"D\u2019Angelo","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.devcel.2021.10.001_bib2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/neuonc\/noab047","article-title":"A Phase 2 Trial of Selumetinib in Children\u00a0with Recurrent Optic Pathway and Hypothalamic Low-Grade Glioma without NF1: A Pediatric Brain Tumor Consortium Study","volume":"10","author":"Fangusaro","year":"2021","journal-title":"Neuro-oncol."},{"key":"10.1016\/j.devcel.2021.10.001_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-021-02276-5","article-title":"Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)","volume":"141","author":"Fisher","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.devcel.2021.10.001_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2021.08.004","article-title":"Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors","volume":"56","author":"Jecrois","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.devcel.2021.10.001_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2012.05.036","article-title":"Innate neural stem cell heterogeneity determines the patterning of glioma formation in children","volume":"22","author":"Lee","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.devcel.2021.10.001_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0896-6273(00)80939-3","article-title":"Focal ventricular origin and migration of oligodendrocyte precursors into the chick optic nerve","volume":"19","author":"Ono","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.devcel.2021.10.001_bib7","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00429-017-1394-2","article-title":"Oligodendrocyte precursor cells in the mouse optic nerve originate in the preoptic area","volume":"222","author":"Ono","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.devcel.2021.10.001_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/neuonc\/noaa036","article-title":"Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference","volume":"22","author":"Packer","year":"2020","journal-title":"Neuro-oncol."},{"key":"10.1016\/j.devcel.2021.10.001_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1126\/science.8235590","article-title":"Programmed cell death and the control of cell survival: lessons from the nervous system","volume":"262","author":"Raff","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.devcel.2021.10.001_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"}],"container-title":["Developmental Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1534580721007711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1534580721007711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:41:44Z","timestamp":1761522104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1534580721007711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":10,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1534580721007711"],"URL":"https:\/\/doi.org\/10.1016\/j.devcel.2021.10.001","relation":{},"ISSN":["1534-5807"],"issn-type":[{"value":"1534-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of ERK\/MAPK signaling as potential therapy to prevent optic pathway glioma in infants with neurofibromatosis type 1","name":"articletitle","label":"Article Title"},{"value":"Developmental Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.devcel.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.devcel.2021.08.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}